vVARDIS
PrivateLast Round
Early Funding
Apr 27, 2026
Est. Valuation
$1B
Momentum Score
25 /100
Company Overview
vVARDIS is a healthcare company that develops and manufactures biomimetic, non-invasive dental products for professionals designed for the drill-free treatment of early tooth decay.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, D2C Brands, Fashion & Beauty
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
vVARDIS Comps
Public and private peers based on sector, stage, and business model.
vVARDIS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 27, 2026 | ||||
| VC Round | Jul 15, 2025 | ||||
| VC Round | Feb 11, 2025 |
vVARDIS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OrbiMed | VC Round |
| Apollo Funds | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 27, 2026
Raised $1B post-money valuation led by Apollo Global Management.
vVARDIS Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about vVARDIS's valuation, stock price, and market status.
